Arvinas, Inc. (ARVN)
11.83
-0.07
(-0.59%)
USD |
NASDAQ |
Dec 30, 10:10
Arvinas Total Liabilities (Quarterly): 279.90M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Verastem, Inc. | 192.38M |
| Sarepta Therapeutics, Inc. | 2.173B |
| Genprex, Inc. | 2.795M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 844.30M |
| Shareholders Equity (Quarterly) | 564.40M |
| Debt to Equity Ratio | 0.0168 |
| Current Ratio | 5.703 |
| Net Debt Paydown Yield | -0.24% |